|
84
|
275
|
6i8zA |
Crystal structure of ptk2 in complex with bi-4464. |
|
95
|
311
|
6hp9A |
Structure of the kinase domain of human ddr1 in complex with a 2-amino-2,3-dihydro-1h-indene-5-carboxamide-based inhibitor |
|
77
|
287
|
6hhoA |
Crystal structure of rip1 kinase in complex with gsk547 |
|
95
|
297
|
6egfB |
Crystal structure of the inactive unphosphorylated irak4 kinase domain bound to amp-pnp |
|
86
|
301
|
6c1cA |
Fgfr1 kinase complex with inhibitor sn37116 |
|
92
|
295
|
6egeA |
Crystal structure of the unphosphorylated irak4 kinase domain bound to a type i inhibitor |
|
83
|
301
|
6c18A |
Fgfr1 kinase complex with inhibitor sn37115 |
|
77
|
277
|
6ateA |
Src kinase bound to covalent inhibitor |
|
92
|
296
|
6eg9A |
Irak4 in complex with ponatinib |
|
85
|
294
|
6egaA |
Irak4 in complex with a type ii inhibitor |
|
98
|
308
|
6cdtA |
Structure of human anaplastic lymphoma kinase domain |
|
93
|
294
|
6egdA |
Crystal structure of the unphosphorylated irak4 kinase domain bound to a type i inhibitor |
|
87
|
302
|
6c19A |
Fgfr1 kinase complex with inhibitor sn36985 |
|
83
|
302
|
6c1oA |
Fgfr1 kinase domain complexed with fiin-1 |
|
87
|
301
|
6c1bA |
Fgfr1 kinase complex with inhibitor sn37118 |
|
66
|
286
|
6r5fA |
Crystal structure of rip1 kinase in complex with dhp77 |
|
87
|
299
|
5z0sA |
Crystal structure of fgfr1 kinase domain in complex with a novel inhibitor |
|
76
|
287
|
6ocqA |
Crystal structure of rip1 kinase in complex with a pyrrolidine |
|
91
|
287
|
6nw2A |
Structure of human ripk1 kinase domain in complex with compound 11 |
|
24
|
196
|
6j5uC |
Ligand-triggered allosteric adp release primes a plant nlr complex |
|
27
|
233
|
6j6iA |
Reconstitution and structure of a plant nlr resistosome conferring immunity |
|
33
|
196
|
6j5vC |
Ligand-triggered allosteric adp release primes a plant nlr complex |
|
94
|
263
|
6hrpA |
Crystal structure of btk kinase domain complexed with 6-(dimethylamino)-2-[2-(hydroxymethyl)-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridyl]amino]-6-oxo-3-pyridyl]phenyl]-3,4-dihydroisoquinolin-1-one |
|
92
|
268
|
6o8iA |
Btk in complex with inhibitor |
|
93
|
290
|
6n7aA |
Structure of the human jak1 kinase domain with compound 39 |
|
93
|
289
|
6n77A |
Structure of the human jak1 kinase domain with compound 15 |
|
87
|
289
|
6n79A |
Structure of the human jak1 kinase domain with compound 20 |
|
93
|
290
|
6n7dA |
Structure of the human jak1 kinase domain with compound 54 |
|
84
|
299
|
6jpjA |
Crystal structure of fgf401 in complex of fgfr4 |
|
92
|
290
|
6n7cA |
Structure of the human jak1 kinase domain with compound 56 |
|
89
|
289
|
6n78A |
Structure of the human jak1 kinase domain with compound 21 |
|
91
|
290
|
6n7bA |
Structure of the human jak1 kinase domain with compound 38 |
|
35
|
233
|
6j5tA |
Reconstitution and structure of a plant nlr resistosome conferring immunity |
|
84
|
274
|
6gcxA |
Focal adhesion kinase catalytic domain in complex with irreversible inhibitor |
|
82
|
304
|
6ebwA |
Halk in complex with compound 9 (6-(((1s)-1-(5-fluoropyridin-2-yl)ethyl)amino)-1-(3-methyl-1h-pyrazol-5-yl)-1h-pyrrolo[2,3-b]pyridin-3-yl)(morpholin-4-yl)methanone |
|
91
|
263
|
6hrtA |
Crystal structure of btk kinase domain complexed with 12-(6-tert-butyl-8-fluoro-1-oxo-phthalazin-2-yl)-9-hydroxy-6-methyl-4-[[5-(morpholine-4-carbonyl)-2-pyridyl]amino]-6-azatricyclo[9.4.0.02,7]pentadeca-1(15),2(7),3,11,13-pentaen-5-one |
|
91
|
301
|
6e0rA |
Halk in complex with compound 7 n-((1s)-1-(5-fluoropyridin-2-yl)ethyl)-1-(5-methyl-1h-pyrazol-3-yl)-3-(oxetan-3-ylsulfonyl)-1h-pyrrolo[2,3-b]pyridin-6-amine |
|
83
|
272
|
6gcwA |
Focal adhesion kinase catalytic domain in complex with irreversible inhibitor |
|
88
|
272
|
6gcrA |
Focal adhesion kinase catalytic domain in complex with irreversible inhibitor |
|
87
|
307
|
6edlA |
Halk in complex with compound 1 (s)-n-(1-(2,4-difluorophenyl)ethyl)-3-(3-methyl-1h-pyrazol-5-yl)imidazo[1,2-b]pyridazin-6-amine |
|
86
|
272
|
6g3cA |
Crystal structure of jak2-v617f pseudokinase domain in complex with compound 2 |
|
75
|
273
|
6d2iA |
Jak2 pseudokinase v617f in complex with at9283 |
|
98
|
296
|
6acrA |
Crystal structure of human alk2 kinase domain with r206h mutation in complex with rk-59638 |
|
83
|
306
|
5j9lA |
Crystal structure of cpt1691 bound to tak1-tab1 |
|
103
|
310
|
3u6jA |
Crystal structure of the vegfr2 kinase domain in complex with a pyrazolone inhibitor |
|
84
|
272
|
3tubA |
Crystal structure of syk kinase domain with 1-(5-(6,7-dimethoxyquinolin-4-yloxy)pyridin-2-yl)-3-((1r,2s)-2-phenylcyclopropyl)urea |
|
84
|
274
|
3tudA |
Crystal structure of syk kinase domain with n-(4-methyl-3-(8-methyl-7-oxo-2-(phenylamino)-7,8-dihydropyrido[2,3-d]pyrimidin-6-yl)phenyl)-3-(trifluoromethyl)benzamide |
|
86
|
301
|
3u6iA |
Crystal structure of c-met in complex with pyrazolone inhibitor 58a |
|
79
|
276
|
3uqfA |
C-src kinase domain in complex with bki rm-1-89 |
|
81
|
276
|
3tucA |
Crystal structure of syk kinase domain with 1-benzyl-n-(5-(6,7-dimethoxyquinolin-4-yloxy)pyridin-2-yl)-2-oxo-1,2-dihydropyridine-3-carboxamide |
